Dr. Wang received the payments from a variety of medical device companies, including Medtronic, DePuy and FzioMed, while investigating the use of their products from 2004-2007. The payments included royalties on products developed by Dr. Wang as well as speaking and consulting fees.
Records regarding Dr. Wang’s payments were obtained by congressional investigators, who sent a letter to UCLA’s chancellor regarding the failed disclosure.
According to the report, Dr. Wang indicated he received less than $500 in payment from Medtronic in 2007, but records show that Medtronic paid $14,600 to Dr. Wang for a single week-long engagement in January of that year.
Read the Wall Street Journal report on Dr. Wang’s failure to disclose payments.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
